News: Philip Morris International Inc (PM)

PM on New York Consolidated

83.51USD
1 Oct 2014
Price Change (% chg)

$0.11 (+0.13%)
Prev Close
$83.40
Open
$83.25
Day's High
$83.88
Day's Low
$83.21
Volume
3,718,664
Avg. Vol
3,925,432
52-wk High
$91.81
52-wk Low
$75.28

Search Stocks
Select another date:

Thu, Aug 28 2014

From stock-pickers to pensioners, Fed board filings show millionaires

WASHINGTON - The five members of the Federal Reserve board that oversee U.S. monetary policy have plenty of money of their own, according to government filings released on Thursday.

Philip Morris ordered to defend fraud suit over U.S. military vendors

WASHINGTON - A U.S. appeals court on Tuesday revived a lawsuit against Philip Morris USA Inc that claims the tobacco company defrauded the federal government by failing to sell cigarettes to military vendors at the lowest price.

Philip Morris ordered to defend fraud suit over U.S. military vendors

WASHINGTON, Aug 26 - A U.S. appeals court on Tuesday revived a lawsuit against Philip Morris USA Inc that claims the tobacco company defrauded the federal government by failing to sell cigarettes to military vendors at the lowest price.

Czech Philip Morris H1 net profit up 23 percent

PRAGUE, Aug 19 - Consolidated net profit at Czech tobacco group Philip Morris CR rose 23 percent to 1.1 billion crowns ($52.67 million) in the first half, helped by better pricing in its markets.

RPT-FEATURE-Tobacco-derived 'plantibodies' enter the fight against Ebola

NEW YORK, Aug 6 - Drugmakers' use of the tobacco plant as a fast and cheap way to produce novel biotechnology treatments is gaining global attention because of its role in an experimental Ebola therapy.

Tobacco-derived 'plantibodies' enter the fight against Ebola

NEW YORK - Drugmakers' use of the tobacco plant as a fast and cheap way to produce novel biotechnology treatments is gaining global attention because of its role in an experimental Ebola therapy.

FEATURE-Tobacco-derived 'plantibodies' enter the fight against Ebola

NEW YORK, Aug 6 - Drugmakers' use of the tobacco plant as a fast and cheap way to produce novel biotechnology treatments is gaining global attention because of its role in an experimental Ebola therapy.

UPDATE 2-Essentra profit rises as cigarette filter sales grow

* Shares rise as much as 3.5 pct (Adds details, CEO comment, share price)

RPT-Fitch Affirms Philip Morris International at 'A'; Outlook Stable

July 8 - (The following statement was released by the rating agency)

Philip Morris seeks review of EU tobacco law

LONDON, June 27 - Marlboro cigarette maker Philip Morris International is seeking to challenge Europe's new laws on tobacco products, the latest clash between Big Tobacco and governments seeking tighter regulation.

Select another date:

Press Releases

Search Stocks